Exclusive

Publication

Byline

Location

US Patent Issued to SHUJING BIOPHARMA, JIANGSU NHWA PHARMACEUTICAL on Sept. 1 for "Heterocyclic substituted fused Gamma-carboline derivative, preparation method therefor, intermediate thereof and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,044, issued on Sept. 1, was assigned to SHUJING BIOPHARMA Co. LTD (Shanghai) and JIANGSU NHWA PHARMACEUTICAL Co. LTD (Xuzhou, China). "Hete... Read More


US Patent Issued to MOMA Therapeutics on Sept. 1 for "Tricyclic derivatives and related uses" (Massachusetts, California, Indiana Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,045, issued on Sept. 1, was assigned to MOMA Therapeutics Inc. (Cambridge, Mass.). "Tricyclic derivatives and related uses" was invented by... Read More


US Patent Issued to Eli Lilly and Co. on Sept. 1 for "cGAS inhibitors" (American, Spanish Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,046, issued on Sept. 1, was assigned to Eli Lilly and Co. (Indianapolis). "cGAS inhibitors" was invented by Francisco Javier Agejas Chichar... Read More


US Patent Issued to Amgen on Sept. 1 for "Heterocyclic spiro compounds and methods of use" (American, Indian Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,047, issued on Sept. 1, was assigned to Amgen Inc. (Thousand Oaks, Calif.). "Heterocyclic spiro compounds and methods of use" was invented ... Read More


US Patent Issued to BeOne Medicines | on Sept. 1 for "5-amino-6,8-dihydro-1H-furo[3,4-dpyrrolo[3,2-bpyridine-2-carboxamide derivatives as MTA-cooperative inhibitors of PRMT5" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,048, issued on Sept. 1, was assigned to BeOne Medicines | GmbH (Basel, Switzerland). "5-amino-6,8-dihydro-1H-furo[3,4-dpyrrolo[3,2-bpyridin... Read More


US Patent Issued to PTC Therapeutics on Sept. 1 for "Methods for treating spinocerebellar ataxia type 3" (New Jersey Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,049, issued on Sept. 1, was assigned to PTC Therapeutics Inc. (Warren, N.J.). "Methods for treating spinocerebellar ataxia type 3" was inve... Read More


US Patent Issued to TENNOR THERAPEUTICS (SUZHOU) on Sept. 1 for "Crystal form of compound and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,050, issued on Sept. 1, was assigned to TENNOR THERAPEUTICS (SUZHOU) Ltd. (Suzhou, China). "Crystal form of compound and use thereof" was i... Read More


US Patent Issued to LG CHEM on Sept. 1 for "Compound and organic light emitting device comprising the same" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,051, issued on Sept. 1, was assigned to LG CHEM Ltd. (Seoul, South Korea). "Compound and organic light emitting device comprising the same"... Read More


US Patent Issued to Eli Lilly and Co. on Sept. 1 for "KRas inhibitors" (American, Spanish Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,053, issued on Sept. 1, was assigned to Eli Lilly and Co. (Indianapolis). "KRas inhibitors" was invented by Adedoyin David Abraham (Thornto... Read More


US Patent Issued to Samsung Display on Sept. 1 for "Organic molecules for optoelectronic devices" (German Inventor)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,054, issued on Sept. 1, was assigned to Samsung Display Co. Ltd. (Yongin-si, South Korea). "Organic molecules for optoelectronic devices" w... Read More